Resistin impairs basal and insulin-induced glycogen synthesis by different mechanisms

Molecular and Cellular Endocrinology

Volumn 263, Issue 1-2, 2007, Pages 112-119

  Niederwanger, Andreas ^a   Kranebitter, Michael ^a   Ciardi, Christian ^a   Tatarczyk, Tobias ^a   Patsch, Josef R ^a   Pedrini, Michael T ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Glycogen synthesis; Hexokinase; Insulin resistance; Insulin signaling; L6 skeletal muscle cells; Resistin

Indexed keywords

GLUCOSE; GLUCOSE 6 PHOSPHATE; GLYCOGEN; HEXOKINASE; INSULIN; RESISTIN;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; COVALENT BOND; DRUG EFFECT; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HORMONAL REGULATION; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; CELLS, CULTURED; GLUCOSE; GLUCOSE-6-PHOSPHATE; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; HEXOKINASE; HYPOGLYCEMIC AGENTS; IMMUNOBLOTTING; INSULIN; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RESISTIN;

EID: 37849187011     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.09.007     Document Type: Article

References (39)

1. Atzmon G., Yang X.M., Muzumdar R., Ma X.H., Gabriely I., and Barzilai N. Differential gene expression between visceral and subcutaneous fat depots. Horm. Metab. Res. 34 (2002) 622-628
2. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., et al. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
3. Baumann C.A., Ribon V., Kanzaki M., Thurmond D.C., Mora S., Shigematsu S., Bickel P.E., Pessin J.E., and Saltiel A.R. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407 (2000) 202-207
4. Chiang S.H., Baumann C.A., Kanzaki M., Thurmond D.C., Watson R.T., Neudauer C.L., Macara I.G., Pessin J.E., and Saltiel A.R. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410 (2001) 944-948
5. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B.E., Watson W., Kerr K., Jones R., Zhu Q., and Considine R.V. Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 88 (2003) 5452-5455
6. Gabriely I., Ma X.H., Yang X.M., Atzmon G., Rajala M.W., Berg A.H., Scherer P., Rossetti L., and Barzilai N. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 51 (2002) 2951-2958
7. Groop L., and Orho-Melander M. The dysmetabolic syndrome. J. Intern. Med. 250 (2001) 105-120
8. Harris R.C., Hultman E., and Sahlin K. Glycolytic intermediates in human muscle after isometric contraction. Pflugers Arch. 389 (1981) 277-282
9. Henriksen E.J., Kinnick T.R., Teachey M.K., O'Keefe M.P., Ring D., Johnson K.W., and Harrison S.D. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E892-E900
10. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271 (1996) 10697-10703
11. Kellerer M., Lammers R., Fritsche A., Strack V., Machicao F., Borboni P., Ullrich A., and Haring HU. Insulin inhibits leptin receptor signalling in HEK293 cells at the level of janus kinase-2: a potential mechanism for hyperinsulinaemia-associated leptin resistance. Diabetologia 44 (2001) 1125-1132
12. Keppler D., and Decker K. In: Bergmeyer H., Grassl M., and Bergmeyer J. (Eds). Glycogen. In Methods of Enzymatic Analysis. 3rd ed. (1974), Verlag Chemie International, Deerfield Beach, FL 1127-1131
13. Kim Y.B., Nikoulina S.E., Ciaraldi T.P., Henry R.R., and Kahn B.B. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J. Clin. Invest. 104 (1999) 733-741
14. Krook A., Roth R.A., Jiang X.J., Zierath J.R., and Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47 (1998) 1281-1286
15. Lee J.H., Chan J.L., Yiannakouris N., Kontogianni M., Estrada E., Seip R., Orlova C., and Mantzoros C.S. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 88 (2003) 4848-4856
16. Lemieux S. Contribution of visceral obesity to the insulin resistance syndrome. Can. J. Appl. Physiol. 26 (2001) 273-290
17. Moller D.E. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol. Metab. 11 (2000) 212-217
18. Moon B., Kwan J.J., Duddy N., Sweeney G., and Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E106-E115
19. Muse E.D., Obici S., Bhanot S., Monia B.P., McKay R.A., Rajala M.W., Scherer P.E., and Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114 (2004) 232-239
20. Niederwanger A., Kranebitter M., Ritsch A., Patsch J.R., and Pedrini M.T. A gel filtration assay to determine glycogen synthase activity. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 820 (2005) 143-145
21. Nikoulina S.E., Ciaraldi T.P., Mudaliar S., Mohideen P., Carter L., and Henry R.R. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49 (2000) 263-271
22. Oliver P., Ribot J., Rodriguez A.M., Sanchez J., Pico C., and Palou A. Resistin as a putative modulator of insulin action in the daily feeding/fasting rhythm. Pflugers Arch. 452 (2006) 260-267
23. Palanivel R., Maida A., Liu Y., and Sweeney G. Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin. Diabetologia 49 (2006) 183-190
24. Pedrini M.T., Kranebitter M., Niederwanger A., Kaser S., Engl J., Debbage P., Huber L.A., and Patsch J.R. Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels. Diabetologia 48 (2005) 756-766
25. Pravenec M., Kazdova L., Landa V., Zidek V., Mlejnek P., Jansa P., Wang J., Qi N., and Kurtz T.W. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J. Biol. Chem. 278 (2003) 45209-45215
26. Rajala M.W., Obici S., Scherer P.E., and Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Invest. 111 (2003) 225-230
27. Rajala M.W., Qi Y., Patel H.R., Takahashi N., Banerjee R., Pajvani U.B., Sinha M.K., Gingerich R.L., Scherer P.E., and Ahima R.S. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53 (2004) 1671-1679
28. Rossetti L., and Hu M. Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production. J. Clin. Invest. 92 (1993) 2963-2974
29. Satoh H., Nguyen M.T., Miles P.D., Imamura T., Usui I., and Olefsky J.M. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 114 (2004) 224-231
30. Shalev A., Patterson N.B., Hirshberg B., Rother K.I., and Harlan D.M. Resistin serum levels in type 1 diabetes pre- and post-islet transplantation. Metabolism 53 (2004) 403-404
31. Shulman G.I., Rothman D.L., Jue T., Stein P., DeFronzo R.A., and Shulman R.G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322 (1990) 223-228
32. Silha J.V., and Murphy L.J. Serum resistin (FIZZ3) protein is increased in obese humans 1977-1978. J. Clin. Endocrinol. Metab. 89 (2004) (author reply)
33. Steppan C.M., Wang J., Whiteman E.L., Birnbaum M.J., and Lazar M.A. Activation of SOCS-3 by resistin. Mol. Cell Biol. 25 (2005) 1569-1575
34. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., and Lazar MA. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
35. Villar-Palasi C., and Guinovart J.J. The role of glucose 6-phosphate in the control of glycogen synthase. FASEB J. 11 (1997) 544-558
36. Virtanen K.A., Iozzo P., Hallsten K., Huupponen R., Parkkola R., Janatuinen T., Lonnqvist F., Viljanen T., Ronnemaa T., Lonnroth P., et al. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study. Diabetes 54 (2005) 2720-2726
37. Vogt C., Yki-Jarvinen H., Iozzo P., Pipek R., Pendergrass M., Koval J., Ardehali H., Printz R., Granner D., Defronzo R., et al. Effects of insulin on subcellular localization of hexokinase II in human skeletal muscle in vivo. J. Clin. Endocrinol. Metab. 83 (1998) 230-234
38. Vozarova B., Weyer C., Hanson K., Tataranni P.A., Bogardus C., and Pratley R.E. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res. 9 (2001) 414-417
39. Whitesell R.R., Ardehali H., Printz R.L., Beechem J.M., Knobel S.M., Piston D.W., Granner D.K., Van Der Meer W., Perriott L.M., and May J.M. Control of glucose phosphorylation in L6 myotubes by compartmentalization, hexokinase, and glucose transport. Biochem. J. 370 (2003) 47-56